Kyle Diamantas
Tracked across 7 events · 1456 articles · First seen Apr 16, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Domestic
Impact: Kyle Diamantas will serve as the acting commissioner of the United States — Food and Drug Administration following Marty Makary's resignation, suggesting a potential shift in the agency's approach to various regulatory issues.
May 08, 2026 · 114 articles
Domestic
Impact: Kyle Diamantas, the United States — Food and Drug Administration's deputy commissioner for foods, is tasked with developing a definition for 'ultra-processed foods' and is the first non-scientist to head the United States — Food and Drug Administration in over half a century, raising concerns among critics.
May 13, 2026 · 6 articles
Regulatory
On Monday, the U.S. United States — Food and Drug Administration proposed a rule change that would require food manufacturers to notify the agency before introducing new ingredients or additives into processed or packaged foods.…
Impact: As acting FDA Commissioner, Diamantas is the public face of the proposal, articulating its benefits for postmarket safety.
Aug 10, 2026 · 12 articles
Domestic
President Donald Trump nominated Dr. Heidi Overton, a White House domestic policy aide, to lead the U.S. United States — Food and Drug Administration (FDA). Overton, a physician and deputy director of the White House…
Impact: Diamantas has been acting FDA chief since May, providing some stability. His future role is uncertain under a new commissioner.
Aug 19, 2026 · 101 articles
Accidents
Impact: Acting FDA Commissioner Kyle Diamantas announced the false-positive test result, which complicated the investigation.
Jul 08, 2026 · 358 articles
Regulatory
On August 5, 2026, the U.S. United States — Food and Drug Administration (FDA) approved Moderna's mFLUSIVA (mRNA-1010), the first mRNA-based seasonal influenza vaccine, for adults aged 50 and older. The approval covers traditional approval…
Impact: As acting FDA Commissioner, Diamantas sought to rebuild industry confidence after the controversies.
Aug 05, 2026 · 105 articles
International
Impact: Kyle Diamantas is expected to take over as acting commissioner of the United States — Food and Drug Administration.
Apr 16, 2026 · 760 articles
40
Kyle Diamantas declined positionTrump nominates Heidi...
30
Kyle Diamantas sought to steady agency United States — Food and Drug AdministrationFDA Approves Moderna's...
Marty Makary
successor
↔
Kyle Diamantas
Kyle Diamantas served as the FDA deputy commissioner under Marty Makary. Followi
Marty Makary
predecessor
↔
Kyle Diamantas
Marty Makary led the FDA as commissioner with Kyle Diamantas serving as his depu
ERGEN INTELLIGENCE
Track Kyle Diamantas live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard